Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group(A) in cooperation with the Austrian ARIA Group(B), the Swiss ARIA Group(C), German Society for Applied Allergology (AEDA)(D), German Society for Allergology and Clinical Immunology (DGAKI)(E), Society for Pediatric Allergology (GPA)(F) in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC(G) and the E

当前 COVID-19 大流行期间的过敏原免疫疗法：AeDA、ARIA、EAACI、DGAKI 和 GPA 的立场文件：德国 ARIA 小组 (A) 与奥地利 ARIA 小组 (B)、瑞士 ARIA 小组 (C)、德国应用过敏学会 (AEDA) (D)、德国过敏与临床免疫学会 (DGAKI) (E)、儿科过敏学会 (GPA) (F) 合作撰写的立场文件，并与德国国家卫生研究院 (DGHNO-KHC) 临床免疫学、过敏学和环境医学研究组 (G) 合作撰写。